Interaction between mean arterial pressure and HbA1c in prediction of cardiovascular disease hospitalisation: A population-based case-control study

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Yu, Dahai ^a,b   Zhao, Zhanzheng ^a   Simmons, David ^c  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b KEELE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION BASED CASE CONTROL STUDY; SYSTOLIC BLOOD PRESSURE; ARTERIAL PRESSURE; BLOOD; CASE CONTROL STUDY; COMPLICATION; FACTUAL DATABASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; THEORETICAL MODEL;

ARTERIAL PRESSURE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALIZATION; HUMANS; MODELS, THEORETICAL; PREDICTIVE VALUE OF TESTS;

EID: 84976621253     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/8714745     Document Type: Article

References (21)

1. C. M. Lawes, S. Vander Hoorn, A. Rodgers, and International Society of Hypertension, "Global burden of blood-pressurerelated disease, 2001," The Lancet, vol. 371, pp. 1513-1518, 2008.
2. S. S. Franklin and N. D. Wong, "Hypertension and cardiovascular disease: contributions of the Framingham heart study," Global Heart, vol. 8, no. 1, pp. 49-57, 2013.
3. C. D. A. Stehouwer, R. M. A. Henry, and I. Ferreira, "Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease," Diabetologia, vol. 51, no. 4, pp. 527-539, 2008.
4. S. Kodama, C. Horikawa, K. Fujihara et al., "Meta-analysis of the quantitative relation between pulse pressure and mean arterial pressure and cardiovascular risk in patients with diabetes mellitus," American Journal of Cardiology, vol. 113, no. 6, pp. 1058-1065, 2014.
5. W. Yang, T. M. Dall, P. Halder et al., "Economic costs of diabetes in the U. S. in 2012," Diabetes Care, vol. 36, no. 4, pp. 1033-1046, 2013.
6. D. Simmons and H. Wenzel, "Diabetes inpatients: a case of lose, lose, lose. Is it time to use a diabetes-attributable hospitalization cost to assess the impact of diabetes?" Diabetic Medicine, vol. 28, no. 9, pp. 1123-1128, 2011.
7. A. Cohen-Solal, F. Beauvais, and D. Logeart, "Heart failure and diabetes mellitus: epidemiology and management of an alarming association," Journal of Cardiac Failure, vol. 14, no. 7, pp. 615-625, 2008.
8. G. W. Somes, M. Pahor, R. I. Shorr, W. C. Cushman, and W. B. Applegate, "The role of diastolic blood pressure when treating isolated systolic hypertension," Archives of Internal Medicine, vol. 159, no. 17, pp. 2004-2009, 1999.
9. A.-P. Kengne, S. Czernichow, R. Huxley et al., "Blood pressure variables and cardiovascular risk: new findings from advance," Hypertension, vol. 54, no. 2, pp. 399-404, 2009.
10. C. C. L. Wang and J. E. B. Reusch, "Diabetes and cardiovascular disease: changing the focus fromglycemic control to improving long-term survival," The American Journal of Cardiology, vol. 110, no. 9, pp. 58B-68B, 2012.
11. D. Yu and D. Simmons, "Relationship between HbA1c and risk of all-cause hospital admissions among people with Type 2 diabetes," Diabetic Medicine, vol. 30, no. 12, pp. 1407-1411, 2013.
12. S. Wacholder, J. K. McLaughlin, D. T. Silverman, and J. S. Mandel, "Selection of controls in case-control studies. I. Principles," American Journal of Epidemiology, vol. 135, no. 9, pp. 1019-1028, 1992.
13. K. J. Rothman, S. Greenland, and T. L. Lash, Modern Epidemiology, LippincottWilliams andWilkins, 3rd edition, 2008.
14. D. Y. Lin, "Cox regression analysis of multivariate failure time data: the marginal approach," Statistics in Medicine, vol. 13, no. 21, pp. 2233-2247, 1994.
15. V. M. R. Muggeo, "Estimating regressionmodels with unknown break-points," Statistics in Medicine, vol. 22, no. 19, pp. 3055-3071, 2003.
16. S. S. Franklin, V. A. Lopez, N. D. Wong et al., "Single versus combined blood pressure components and risk for cardiovascular disease the framingham heart study," Circulation, vol. 119, no. 2, pp. 243-250, 2009.
17. H. D. Sesso, M. J. Stampfer, B. Rosner et al., "Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men," Hypertension, vol. 36, no. 5, pp. 801-807, 2000.
18. W. Duckworth, C. Abraira, T. Moritz et al., "Glucose control and vascular complications in veterans with type 2 diabetes," The New England Journal of Medicine, vol. 360, no. 2, pp. 129-139, 2009.
19. P. Ulrich and A. Cerami, "Protein glycation, diabetes, and aging," Recent Progress in Hormone Research, vol. 56, pp. 1-21, 2001.
20. D. A. Kass, E. P. Shapiro, M. Kawaguchi et al., "Improved arterial compliance by a novel advanced glycation end-product crosslink breaker," Circulation, vol. 104, no. 13, pp. 1464-1470, 2001.
21. M. A. Stone, J. Camosso-Stefinovic, J. Wilkinson, S. de Lusignan, A. T. Hattersley, and K. Khunti, "Incorrect and incomplete coding and classification of diabetes: a systematic review," Diabetic Medicine, vol. 27, pp. 491-497, 2010.